[Management of excreta from elderly treated with antineoplastic drugs].

The excreta management of elderly patients treated by chemotherapy is not regularly dealt by a pragmatic process depending cancer treatments. It involves identifying the excreta toxicity, including their chemical classification, cytotoxic nature, renal or fecal exposition time of the drugs. Protective measures must be described to avoid the risk of contact with potentially contaminated excreta by anticancer drugs or their metabolites.

Risk management of excreta in a cancer unit.

Although many legal and clinical requirements are in effect for the preparation and administration of the antineoplasic drugs, limited data exist on the potential cytotoxic risk to healthcare personnel from exposure of excreta (urine, feces, expectorations, saliva, perspiration, and vomiting) from patients. A preliminary risk analysis was conducted with a multidisciplinary work group. The objectives were to identify all potential hazards and accidental events that may lead to an accident related to the excreta management and to implement a global risk reduction and quality improvement policy.